INS and Hypoglycemia: Insulin dosing is recommended to be reduced by 50% to reduce the risk of hypoglycemia among patients with kidney disease; however, it should be continued until the resolution of ketoacidosis while maintaining euglycemia (BG: 140 – 180 mg/dL) (30, 31).